Related Experiment Video
Updated: Mar 24, 2026

06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
5.7K
Integrating Everything: The Molecule Selection Toolkit, a System for Compound Prioritization in Drug Discovery
David J Cummins1, Michael A Bell1
1Eli Lilly and Company , 893 South Delaware Street, Indianapolis, Indiana 46285, United States.
Journal of Medicinal Chemistry
|March 8, 2016
Summary
This study introduces a flexible, adaptable system for pharmaceutical compound prioritization. It integrates predictive modeling and statistical design, moving beyond static solutions for drug discovery.
Area of Science:
- Pharmaceutical Chemistry
- Computational Chemistry
- Drug Discovery
Background:
- Traditional compound prioritization methods in pharmaceutical discovery often rely on static, fixed functions.
- Existing approaches may lack essential design components and require frequent updates as project needs evolve.
Purpose of the Study:
- To present a flexible and comprehensive approach for prioritizing compounds in pharmaceutical discovery.
- To move beyond static optimization functions by incorporating adaptable systems.
Main Methods:
- Development of a comprehensive system integrating predictive modeling.
- Implementation of multiattribute optimization techniques.
- Inclusion of modern statistical design principles for robust evaluation.
Main Results:
- The described approach provides a complete package for effective compound prioritization.
- The system has been successfully utilized in various stages of drug discovery since 2001.
- An adaptable system reduces the need for multiple, static solutions.
Conclusions:
- A flexible, integrated system for compound prioritization offers significant advantages over static methods.
- This approach enhances efficiency in lead generation and lead optimization processes.
- Adaptability is key to addressing evolving project requirements in pharmaceutical research.
Related Concept Videos
Drug Discovery: Overview
12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76

